Tibolone lowers high density lipoprotein cholesterol by increasing hepatic lipase activity but does not impair cholesterol efflux

Clinical Endocrinology

Volumn 58, Issue 1, 2003, Pages 49-58

  Von Eckardstein, Arnold ^a,f   Crook, David ^b   Elbers, Jolanda ^c   Ragoobir, Jennifer ^b   Ezeh, Benjamin ^d   Helmond, Frans ^c   Miller, Norman ^b   Dieplinger, Hans ^d   Coelingh Bennink, Herjan ^e   Assmann, Gerd ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

^c Clinical Development Department   (Netherlands)

^d Inst of Med Biol and Hum Genet   (Austria)

^e Institute for Clinical Concept Research Pantarhei   (Netherlands)

^f UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LIPID TRANSFER PROTEIN; LIPOPROTEIN; LIPOPROTEIN LIPASE; LIVER TRIACYLGLYCEROL LIPASE; PHOSPHATIDYLCHOLINE; PLACEBO; SPHINGOMYELIN; TIBOLONE;

ADULT; ARTICLE; CELL CULTURE; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL TRANSPORT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; ENZYME ACTIVITY; FEMALE; FIBROBLAST; HUMAN; LIPOLYSIS; LIVER CELL; NORMAL HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

CARRIER PROTEINS; CELL CULTURE TECHNIQUES; CHOLESTEROL; CHOLESTEROL, HDL; DOUBLE-BLIND METHOD; ESTROGEN RECEPTOR MODULATORS; FEMALE; HUMANS; LIPASE; LIPIDS; LIVER; MIDDLE AGED; NORPREGNENES;

EID: 0037234656     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2265.2003.01666.x     Document Type: Article

References (46)

1. 2. Journal of Biological Chemistry, 269, 11572-11577.
2. Brinton, E.A. (1996) Oral estrogen replacement therapy in postmenopausal women selectively raises levels and production rates of lipoprotein A-I and lowers hepatic lipase activity without lowering the fractional catabolic rate. Arterioscleriosclerosis, Thrombosis and Vascular Biology, 16, 431-440.
3. Castro, G.R. & Fielding, C.J. (1988) Early incorporation of cell-derived cholesterol into pre-β-migrating high density lipoprotein. Biochemistry, 27, 25-29.
4. Clarkson, T.B., Anthony, M.S. & Wagner, J.D. (2001) A comparison of tibolone and conjugated equine estrogens effects on cornary atherosclerosis and bone density of postmenopausal monkeys. Journal of Clinical Endocrinology and Metabolism, 86, 5396-5404.
5. Crook, D. (1999) Tibolone and the risk of arterial disease. Journal of the British Menopause Society, S1, 30-33.
6. Cushman, M., Legault, C., Barrett-Connor, E., Stefanick, M.L., Kessler, C., Judd, H.L., Sakkinen, P.A. & Tracy, R.P. (1999) Effect of postmenopausal hormones on inflammation-sensitive proteins: The Postmenopausal Estrogen/Progestin Interventions (PEPI) Study. Circulation, 100, 717-722
7. de la Llera Moya, M., Atger, V., Paul, J.L., Fournier, N., Moatti, N., Giral, P., Friday, G.E. & Rothblat, G.M. (1994) A cell culture system for screening human serum for ability to promote cholesterol efflux. Relations between serum components and efflux, esterification, and transfer. Arteriosclerosis and Thrombosis, 14, 1056-1065.
8. Dören, M., Rubig, A., Coelingh Bennink, H.J. & Holzgreve, W. (2000) Resistance of pelvic arteries and plasma lipids in postmenopausal women: Comparative study of tibolone and continuous combined estradiol and norethindrone acetate replacement therapy. American Journal of Obstetrics and Gynecology, 183, 575-582.
9. Fournier, N., Paul, J.-L., Atger, V., Cogny, A., Soni, T., de la Llera-Moya, M., Rothblat, G.M. & Moatti, N. (1997) HDL phospholipid content and composition as a major factor determining cholesterol efflux capacity from Fu5AH cells to human serum. Arteriosclerosis, Thrombosis and Vascular Biology, 17, 2685-2691.
10. Francone, O.L., Royer, L. & Haghpassand, M. (1996) Increased preβ-HDL levels, cholesterol efflux, and LCAT mediated esterification in mice expressing the human cholesteryl ester transfer protein (CETP) and human apolipoprotein A-I (apoA-I) transgenes. Journal of Lipid Research, 37, 1268-1277.
11. Friedewald, W.T., Levy, R.I. & Fredrickson, D.S. (1972) Estimation of the concentration of low density lipoprotein in plasma without use of a preparative ultracentrifuge. Clinical Chemistry, 18, 449-456.
12. Gordon, D. & Rifkind, B.M. (1989) Current concepts: High density lipoproteins - The clinical implications of recent studies. New England Journal of Medicine, 321, 1311-1315.
13. Hedrick, C.C., Castellani, L.W., Wong, H. & Lusis, A.J. (2001) In vivo interactions of apoA-II, apoA-I, and hepatic lipase contributing to HDL structure and antiatherogenic functions. Journal of Lipid Research, 42, 563-570.
14. Huang, Y., Langer, C., Raabe, M., Wiesenhütter, B., Wu, S., Seedorf, U., Maeda, N., Assmann, G. & von Eckardstein, A. (1997) Effects of genotype and diet on cholesterol efflux into plasma and lipoproteins of normal, apolipoprotein A-I-, and apolipoprotein E-deficient mice. Arteriosclerosis Thrombosis and Vascular Biology, 17, 2010-2019.
15. Huang, Y., von Eckardstein, A. & Assmann, G. (1993) Cell-derived unesterified cholesterol recycles between low density lipoproteins and different high density lipoproteins for its effective esterification. Arteriosclerosis and Thrombosis, 13, 445-458.
16. Huang, Y., von Eckardstein, A., Wu, S. & Assmann, G. (1995) Cholesterol efflux, cholesterol esterification, and cholesteryl ester transfer by LpA-I and LpA-I/A-II in native plasma. Arteriosclerosis Thrombosis and Vascular Biology, 15, 1412-1418.
17. Huang, Y., von Eckardstein, A., Wu, S. & Assmann, G. (1996) Effects of the apolipoprotein E-polymorphism on uptake and transfer of cell-derived cholesterol in plasma. Journal of Clinical Investigation, 96, 2693-2701.
18. Hulley, S., Grady, D., Bush, T., Furberg, C., Hernigton, D., Riggs, B. & Vittinghoff, E. (1998) Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Journal of the American Medical Association, 280, 605-613.
19. Ikeada, Y., Takagi, A., Ohkaru, Y., Nogi, K., Iwanaga, T., Kurooka, S. & Yamamoto, A. (1990) A sandwich-enzyme immunoassay for the quantification of lipoprotein lipase and hepatic triglyceride lipase in human postheparin plasma using monoclonal antibodies to the corresponding enzymes. Journal of Lipid Research, 31, 1911-1924.
20. Jauhiainen, M., Metso, J., Pahlman, R., Blomqvist, S., van Tol, A. & Ehnholm, C. (1993) Human plasma phospholipid transfer protein causes high density lipoprotein conversion. Journal of Biological Chemistry, 268, 4032-4036.
21. Jiang, X.-J., Francone, O.L., Bruce, C., Milne, R., Mar, J., Walsh, A., Breslow, J.L. & Tall, A.R. (1996) Increased preβ-high density lipoprotein, aplipoprotein AI, and phospholipid in mice expressing the human phospholipid transfer protein and human apolipoprotein AI transgenes. Journal of Clinical Investigation, 98, 2373-2380.
22. Kloosterboer, L.J. (2001) Tibolone: A steroid with a tissue-specific mode of action. Journal of Steroid Biochemistry and Molecular Biology, 76, 231-238.
23. Mikkola, T.S., Anthony, M.S., Clarkson, T.B. & StClair, R.W. (2002) Cholesterol efflux potential in postmenopausal monkeys treated with tibolone or conjugated estrogens. Metabolism, 51, 523-530.
24. Mosca, L. (2000) The role of hormone replacement therapy in the prevention of postmenopausal heart disease. Archives of Internal Medicine, 160, 2263-2272.
25. Nanjee, M.N., Doran, J.E., Lerch, P.G. & Miller, N.E. (1999) Acute effects of intravenous infusion of ApoA1/phosphatidylcholine discs on plasma lipoproteins in humans. Arteriosclerosis, Thrombosis and Vascular Biology, 19, 979-989.
26. Nofer, J.R., Kehrel, B., Fobker, M., Levkau, B., Assmann, G. & von Eckardstein, A. (2002) HDL and arteriosclerosis: Beyond reverse cholesterol transport. Atherosclerosis, 161, 1-16.
27. Oram, J.F. & Vaughan, A.M. (2000) ABCA1 mediated transport of cellular cholesterol to HDL and apolipoproteins. Current Opinion in Lipidology, 11, 253-260.
28. Rader, D.J., Castro, G., Zech, L.A., Fruchart, J.C. & Brewer, H.B. Jr (1991) In vivo metabolism of apolipoprotein AI on high density lipoprotein particles LpA-I and LpA-I: A-II. Journal of Lipid Research, 32, 1849-1859.
29. Rosseneu, M., Michiels, G., Dekeersgieter, W., Bury, J.B., De Slypere, J.P., Dieplinger, H. & Utermann, G. (1988) Human apolipoprotein A-IV quantitation by sandwich enzyme linked immunosorbent assay. Clinical Chemistry, 34, 739-743.
30. Rossouw, J.E. (1999) Hormone replacement therapy and cardiovascular disease. Current Opinion in Lipidology, 10, 429-434.
31. Rothblat, G.H., de la Llera Moya, M., Atger, V., Kellner-Weibel, G., Williams, D.L. & Phillips, M.C. (1999) Cell cholesterol efflux: Integration of old and new observations provides new insights. Journal of Lipid Research, 40, 781-796.
32. Rye, K.A., Clay, M.A. & Barter, P.J. (1999) Remodelling of high density lipoproteins by plasma factors. Atherosclerosis, 145, 227-237.
33. Schriewer, H., Jabs, H.-U. & Assmann, G. (1982) Zur enzymatischen Bestimmung des HDL Sphingomyelins. Journal of Clinical Chemistry and Clinical Biochemistry, 20, 310-312.
34. Schriewer, H., Jung, G., Emke, F. & Assmann, G. (1983) An economical assay for HDL phosphatidylcholine. Journal of Clinical Chemistry and Clinical Biochemistry, 21, 611-614.
35. Stampfer, M.J. & Colditz, G.A. (1991) Estrogen replacement therapy and coronary heart disease: Quantitative assessment of the epidemiologic evidence. Preventive Medicine, 273, 47-63.
36. Syvanne, M., Castro, G., Dengremont, C., De Geitere, C., Jauhiainen, M., Ehnholm, C., Michelagnoli, S., Franceschini, G., Kahri, J. & Taskinen, M.R. (1996) Cholesterol efflux from Fu5AH hepatoma cells induced by plasma of subjects with or without coronary artery disease and non, insulin, dependent diabetes: Importance of LpA-I: A-II particles and phospholipid transfer protein. Atherosclerosis, 127, 245-253.
37. Tan, K.C., Shiu, S.W., Pang, R.W. & Kung, A.W. (1998) Effects of testosterone replacement on HDL subfractions and apolipoprotein A-I containing lipoproteins. Clinical Endocrinology (Oxford), 48, 187-194.
38. von Eckardstein, A., Funke, H., Chirazi, A., Chen-Haudenschild, C., Schulte, H., Schönfeld, R., Köhler, E., Schwarz, S., Steinmetz, A. & Assmann, G. (1994a) Sex-specific effects of the glutamine/histidine polymorphism in apolipoprotein A-IV on high density lipoprotein metabolism. Arteriosclerosis and Thrombosis, 14, 1114-1120.
39. von Eckardstein, A., Huang, Y. & Assmann, G. (1994b) Physiological role and clinical relevance of high-density lipoprotein subclasses. Current Opinion in Lipidology, 5, 404-416.
40. von Eckardstein, A., Huang, Y., Wu, S., Noseda, G. & Assmann, G. (1995) Reverse cholesterol transport in plasma of patients with different forms of familial high density lipoprotein defiency. Arteriosclerosis Thrombosis and Vascular Biology, 15, 690-701.
41. 1-HDL. Biochimica Biophysica Acta, 1301, 255-261.
42. von Eckardstein, A. & Assmann, G. (2000) Prevention of coronary heart disease by raising of HDL cholesterol? Current Opinion in Lipidology, 11, 627-637.
43. von Eckardstein, A., Nofer, J.R. & Assmann, G. (2001a) HDL and coronary heart disease: Role of cholesterol efflux and reverse cholesterol transport. Arteriosclerosis, Thrombosis and Vascular Biology, 21, 13-27.
44. von Eckardstein, A., Schmiddem, K., Hövels, A., Gülbahce, E., Schuler-Lüttmann, S., Elbers, J., Helmond, F., Coelingh Bennink, H.J.T. & Assmann, G. (2001b) Lowering of HDL cholesterol in post-menopausal women by tibolone is not associated with changes in cholesterol efflux capacity or paraoxonase activity. Atherosclerosis, 159, 433-439.
45. Writing Group for the Women's Health Initiative Investigators (2002) Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results from the Women's Health Initiative randomized controlled trial. Journal of the American Medical Association, 288, 321-333.
46. Zandonella, G., Haalck, L., Spener, F., Faber, K., Paltauf, F. & Hermetter, A. (1995) Inversion of lipase stereospecificity for fluorogenic alkyldiacyl glycerols. Effect of substrate solubilization. European Journal of Biochemistry, 231, 50-55.